These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11030493)
41. [Antiepileptic therapy with valproinic acid. Correlations of side effects and serum levels of valproinic acid]. Fröscher W; Schulz HU; Gugler R Fortschr Med; 1979 Sep; 97(34):1464-6. PubMed ID: 159246 [TBL] [Abstract][Full Text] [Related]
42. Valproic acid for agitation in dementia. Lonergan ET; Cameron M; Luxenberg J Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227 [TBL] [Abstract][Full Text] [Related]
43. Hematological effects of valproate in psychiatric patients: what are the risk factors? Vasudev K; Keown P; Gibb I; McAllister-Williams RH J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063 [TBL] [Abstract][Full Text] [Related]
44. Valproic acid and thrombocytopenia. Morris N; Barr RD; Pai KR; Kelton JG Can Med Assoc J; 1981 Jul; 125(1):63-4. PubMed ID: 6790153 [No Abstract] [Full Text] [Related]
45. Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance. Völler GW; Muschard F Acta Neurol Scand; 1974; 50(3):391-3. PubMed ID: 4525037 [No Abstract] [Full Text] [Related]
46. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate. Finsterer J; Pelzl G; Hess B Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896 [TBL] [Abstract][Full Text] [Related]
47. Sodium valproate and thrombocytopenia. Hoffman LM Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479 [No Abstract] [Full Text] [Related]
48. A placebo-controlled trial of valproate in tardive dyskinesia. Nasrallah HA; Dunner FJ; McCalley-Whitters M Biol Psychiatry; 1985 Feb; 20(2):205-8. PubMed ID: 3918588 [No Abstract] [Full Text] [Related]
50. Pharmacokinetics and safety of extended-release divalproex sodium tablets: morning versus evening administration. Dutta S; Reed RC; Cavanaugh JH Am J Health Syst Pharm; 2004 Nov; 61(21):2280-3. PubMed ID: 15552635 [TBL] [Abstract][Full Text] [Related]
51. Transient thrombocytopenia in a child on sodium valproate. Cole AP Dev Med Child Neurol; 1978 Aug; 20(4):487-90. PubMed ID: 357235 [No Abstract] [Full Text] [Related]
52. [Thrombocyte values in adults during the treatment with DPA (Ergenyl)]. Krause KH Med Welt; 1977 Jun; 28(24):1098-9. PubMed ID: 331015 [No Abstract] [Full Text] [Related]
53. Thrombocytopenia secondary to high valproate levels in children with epilepsy. Delgado MR; Riela AR; Mills J; Browne R; Roach ES J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412 [TBL] [Abstract][Full Text] [Related]
54. Sodium valproate in the treatment of resistant epilepsy. Hassan MN; Laljee HC; Parsonage MJ Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682 [TBL] [Abstract][Full Text] [Related]
55. A double-blind, multiple-dose, placebo-controlled, cross-over study to compare the incidence of gastrointestinal complaints in healthy subjects given Doryx R and Vibramycin R. Berger RS J Clin Pharmacol; 1988 Apr; 28(4):367-70. PubMed ID: 3392234 [TBL] [Abstract][Full Text] [Related]
56. Delayed thrombocytopenia after valproic acid overdose. Lin WC; Tsao JH; Tsai SJ Gen Hosp Psychiatry; 2008; 30(5):489-90. PubMed ID: 18774438 [No Abstract] [Full Text] [Related]
57. Divalproex sodium in headache: literature review and clinical guidelines. Silberstein SD Headache; 1996 Oct; 36(9):547-55. PubMed ID: 8916563 [TBL] [Abstract][Full Text] [Related]
58. Valproic acid-induced thrombocytopenia may cause wound nonhealing in individuals with schizophrenia. Tseng YT; Ho PS; Wang CF; Liang CS Psychosomatics; 2015; 56(4):410-3. PubMed ID: 25016351 [No Abstract] [Full Text] [Related]